Hans Biomed USA, Inc.

Hans Biomed USA, Inc. is a global biotechnology company specializing in biologics, medical devices, and professional cosmeceutical products. The company focuses on aesthetic medical devices, bone graft materials, acellular dermal matrix (ADM) products, and skin booster formulas. Hans Biomed holds FDA 510(k) clearances for multiple products and maintains registered patents in 10 countries. Key product lines include MINT™ PDO (polydioxanone-based aesthetic device), klárdie Skin Booster, and MINT Microcannula™ for minimally invasive aesthetic procedures. The company operates three dedicated R&D centers globally and was the first in its industry to be listed on KOSDAQ in South Korea. Hans Biomed serves aesthetic medicine practitioners and medical device providers seeking innovative biologics and tissue engineering solutions. The company combines tissue engineering expertise with aesthetic and reconstructive medical device offerings, positioning itself as a comprehensive provider for practitioners in aesthetic medicine and reconstructive surgery markets.